Stocks and Investing
Stocks and Investing
Thu, March 4, 2021
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
David Lewis Maintained (TMDX) at Hold with Increased Target to $38 on, Mar 4th, 2021
David Lewis of Morgan Stanley, Maintained "TransMedics Group, Inc." (TMDX) at Hold with Increased Target from $16 to $38 on, Mar 4th, 2021.
David, nor any peers, have made any analyst calls on TMDX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources